-
1
-
-
0035746540
-
Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial
-
Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL,Mackey J, Kishnani PS, Smith W, McVie-Wylie A, Sullivan JA, Hoganson GE, Phillips JA 3rd, Schaefer GB, Charrow J, Ware RE, Bossen EH, Chen YT (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3:132-138
-
(2001)
Genet Med
, vol.3
, pp. 132-138
-
-
Amalfitano, A.1
Bengur, A.R.2
Morse, R.P.3
Majure, J.M.4
Case, L.E.5
Veerling, D.L.6
Mackey, J.7
Kishnani, P.S.8
Smith, W.9
McVie-Wylie, A.10
Sullivan, J.A.11
Hoganson, G.E.12
Phillips III, J.A.13
Schaefer, G.B.14
Charrow, J.15
Ware, R.E.16
Bossen, E.H.17
Chen, Y.T.18
-
2
-
-
34247575220
-
Late-onset GSDII with novel GAA gene mutation [3]
-
DOI 10.1111/j.1399-0004.2007.00785.x
-
Angelini C, Nascimbeni AC (2007) Late-onset GSDII with novel GAA gene mutation. Clin Genet 71:374-375 (Pubitemid 46680805)
-
(2007)
Clinical Genetics
, vol.71
, Issue.4
, pp. 374-375
-
-
Angelini, C.1
Nascimbeni, A.C.2
-
3
-
-
84862518548
-
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years
-
Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E, Moggio M, Filosto M, Sette E, Crescimanno G, Tonin P, Parini R, Morandi L, Marrosu G, Greco G, Musumeci O, Di Iorio G, Siciliano G, Donati MA, Carubbi F, Ermani M, Mongini T, Toscano A (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol 259:952-958
-
(2012)
J Neurol
, vol.259
, pp. 952-958
-
-
Angelini, C.1
Semplicini, C.2
Ravaglia, S.3
Bembi, B.4
Servidei, S.5
Pegoraro, E.6
Moggio, M.7
Filosto, M.8
Sette, E.9
Crescimanno, G.10
Tonin, P.11
Parini, R.12
Morandi, L.13
Marrosu, G.14
Greco, G.15
Musumeci, O.16
Di Iorio, G.17
Siciliano, G.18
Donati, M.A.19
Carubbi, F.20
Ermani, M.21
Mongini, T.22
Toscano, A.23
more..
-
4
-
-
0036644465
-
ATS statement: Guidelines for the sixminute walk test
-
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
-
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 166:111-117
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 111-117
-
-
-
5
-
-
0033541105
-
A diagnostic protocol for adult-onset glycogen storage disease type II
-
Ausems MG, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJJ, Wokke JH (1999) A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 52:851-853 (Pubitemid 29120196)
-
(1999)
Neurology
, vol.52
, Issue.4
, pp. 851-853
-
-
Ausems, M.G.E.M.1
Lochman, P.2
Van Diggelen, O.P.3
Ploos, V.A.H.K.4
Reuser, A.J.J.5
Wokke, J.H.J.6
-
6
-
-
84856212433
-
Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience
-
Bali DS, Goldstein JL, Banugaria S, Dai J, Mackey J, Rehder C, Kishnani PS (2012) Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience. Am J Med Genet C: Semin Med Genet 160C:40-49
-
(2012)
Am J Med Genet C: Semin Med Genet
, vol.160 C
, pp. 40-49
-
-
Bali, D.S.1
Goldstein, J.L.2
Banugaria, S.3
Dai, J.4
Mackey, J.5
Rehder, C.6
Kishnani, P.S.7
-
7
-
-
58149380149
-
Diagnosis of glycogenosis type II
-
Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, Musumeci O, Parenti G, Ravaglia S, Seidita F, Toscano A, Vianello A (2008) Diagnosis of glycogenosis type II. Neurology 71:S4-S11
-
(2008)
Neurology
, vol.71
-
-
Bembi, B.1
Cerini, E.2
Danesino, C.3
Donati, M.A.4
Gasperini, S.5
Morandi, L.6
Musumeci, O.7
Parenti, G.8
Ravaglia, S.9
Seidita, F.10
Toscano, A.11
Vianello, A.12
-
8
-
-
79952599466
-
Long-term observational, nonrandomized study of enzyme replacement therapy in late-onset glycogenosis type II
-
Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R, Rigoldi M, Moglia A, Costa A, Carlucci A, Danesino C, Pittis MG, Dardis A, Ravaglia S (2010) Long-term observational, nonrandomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33:727-735
-
(2010)
J Inherit Metab Dis
, vol.33
, pp. 727-735
-
-
Bembi, B.1
Pisa, F.E.2
Confalonieri, M.3
Ciana, G.4
Fiumara, A.5
Parini, R.6
Rigoldi, M.7
Moglia, A.8
Costa, A.9
Carlucci, A.10
Danesino, C.11
Pittis, M.G.12
Dardis, A.13
Ravaglia, S.14
-
9
-
-
0020410785
-
Psycho-physical bases of perceived exertion
-
Borg GAV (1982) Psycho-physical bases of perceived exertion.Med Sci Sports Exerc 14:377-381
-
(1982)
Med Sci Sports Exerc
, vol.14
, pp. 377-381
-
-
Borg, G.A.V.1
-
10
-
-
0001216507
-
Acid maltase deficiency
-
Engel A, Franzini-Armstrong C (eds) McGraw-Hill, New York
-
Engel AG, Hirschhorn R (1994) Acid maltase deficiency. In: Engel A, Franzini-Armstrong C (eds) Myology: basic and clinical. McGraw-Hill, New York, pp 1533-1553
-
(1994)
Myology: Basic and Clinical
, pp. 1533-1553
-
-
Engel, A.G.1
Hirschhorn, R.2
-
11
-
-
33947310954
-
Six-minute walk test in children and adolescents
-
Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fisher V, Geiger H, Loeckinger A, Stein JI (2007) Six-minute walk test in children and adolescents. J Pediatr 150:395-399
-
(2007)
J Pediatr
, vol.150
, pp. 395-399
-
-
Geiger, R.1
Strasak, A.2
Treml, B.3
Gasser, K.4
Kleinsasser, A.5
Fisher, V.6
Geiger, H.7
Loeckinger, A.8
Stein, J.I.9
-
12
-
-
33644994280
-
Course of disability and respiratory function in untreated late-onset Pompe disease
-
DOI 10.1212/01.wnl.0000198776.53007.2c, PII 0000611420060228000029
-
Hagemans ML, Hop WJ, Van Doorn PA, Reuser AJ, Van der Ploeg AT (2006) Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 66:581-583 (Pubitemid 43739893)
-
(2006)
Neurology
, vol.66
, Issue.4
, pp. 581-583
-
-
Hagemans, M.L.C.1
Hop, W.J.C.2
Van Doom, P.A.3
Reuser, A.J.J.4
Van Der, P.A.T.5
-
13
-
-
21144449402
-
Disease severity in children and adults with Pompe disease related to age and disease duration
-
DOI 10.1212/01.WNL.0000165979.46537.56
-
Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2005) Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64:2139-2141 (Pubitemid 40881011)
-
(2005)
Neurology
, vol.64
, Issue.12
, pp. 2139-2141
-
-
Hagemans, M.L.C.1
Winkel, L.P.F.2
Hop, W.C.J.3
Reuser, A.J.J.4
Van Doorn, P.A.5
Van Der, P.A.T.6
-
14
-
-
0000995321
-
Glycogen storage disease type II: Acid α-glucosidase (acid maltase) deficiency
-
Scriver CR, Beaudet AL, Sly WS, Valle D (eds) McGraw-Hill, New York
-
Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3389-3420
-
(2001)
The Metabolic and Molecular Bases of Inherited Disease, 8th Edn.
, pp. 3389-3420
-
-
Hirschhorn, R.1
Reuser, A.J.J.2
-
15
-
-
33846033132
-
Recombinant human acid alpha-glucosidase: Major clinical benefits in infantile-onset Pompe disease
-
DOI 10.1212/01.wnl.0000251268.41188.04, PII 0000611420070109000007
-
Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De la Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE (2007) Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantileonset Pompe disease. Neurology 68:99-109 (Pubitemid 46071892)
-
(2007)
Neurology
, vol.68
, Issue.2
, pp. 99-109
-
-
Kishnani, P.S.1
Corzo, D.2
Nicolino, M.3
Byrne, B.4
Mandel, H.5
Hwu, W.L.6
Leslie, N.7
Levine, J.8
Spencer, C.9
McDonald, M.10
Li, J.11
Dumontier, J.12
Halberthal, M.13
Chien, Y.H.14
Hopkin, R.15
Vijayaraghavan, S.16
Gruskin, D.17
Bartholomew, D.18
Van Der, P.A.19
Clancy, J.P.20
Parini, R.21
Morin, G.22
Beck, M.23
De La, G.G.S.24
Jokic, M.25
Thurberg, B.26
Richards, S.27
Bali, D.28
Davison, M.29
Worden, M.A.30
Chen, Y.T.31
Wraith, J.E.32
more..
-
16
-
-
33646830132
-
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
-
Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671-676
-
(2006)
J Pediatr
, vol.148
, pp. 671-676
-
-
Kishnani, P.S.1
Hwu, W.L.2
Mandel, H.3
Nicolino, M.4
Yong, F.5
Corzo, D.6
-
17
-
-
15044345490
-
Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: Results of a phase II clinical trial
-
DOI 10.1016/j.nmd.2004.10.009
-
Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Gorlinger K, Wallot M, Richards S, Voit T (2005) Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord 15:24-31 (Pubitemid 41556629)
-
(2005)
Neuromuscular Disorders
, vol.15
, Issue.1
, pp. 24-31
-
-
Klinge, L.1
Straub, V.2
Neudorf, U.3
Schaper, J.4
Bosbach, T.5
Gorlinger, K.6
Wallot, M.7
Richards, S.8
Voit, T.9
-
18
-
-
0034621779
-
CDC growth charts: United States
-
Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1-27
-
(2000)
Adv Data
, vol.314
, pp. 1-27
-
-
Kuczmarski, R.J.1
Ogden, C.L.2
Grummer-Strawn, L.M.3
Flegal, K.M.4
Guo, S.S.5
Wei, R.6
Mei, Z.7
Curtin, L.R.8
Roche, A.F.9
Johnson, C.L.10
-
19
-
-
0021331062
-
Childhood acid maltase deficiency. A clinical, biochemical, and morphologic study of three patients
-
Matsuishi T, Yoshino M, Terasawa K, Nonaka I (1984) Childhood acid maltase deficiency: a clinical, biochemical, and morphologic study of three patients. Arch Neurol 41:47-52 (Pubitemid 14214309)
-
(1984)
Archives of Neurology
, vol.41
, Issue.1
, pp. 47-52
-
-
Matsuishi, T.1
Yoshino, M.2
Terasawa, K.3
Nonaka, I.4
-
20
-
-
21744460289
-
Standardisation of spirometry
-
DOI 10.1183/09031936.05.00034805
-
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J (2005) Standardisation of spirometry. Eur Respir J 26:319-338 (Pubitemid 41079078)
-
(2005)
European Respiratory Journal
, vol.26
, Issue.2
, pp. 319-338
-
-
Miller, M.R.1
Hankinson, J.2
Brusasco, V.3
Burgos, F.4
Casaburi, R.5
Coates, A.6
Crapo, R.7
Enright, P.8
Van Der Grinten, C.P.M.9
Gustafsson, P.10
Jensen, R.11
Johnson, D.C.12
MacIntrye, N.13
McKay, R.14
Navajas, D.15
Pedersen, O.F.16
Pellegrino, R.17
Viegi, G.18
Wagner, J.19
-
21
-
-
0000314638
-
Over idiopathische hypertrophie van het hart
-
Pompe JC (1932) Over idiopathische hypertrophie van het hart. Ned Tijdschr Geneeskd 76:304-312
-
(1932)
Ned Tijdschr Geneeskd
, vol.76
, pp. 304-312
-
-
Pompe, J.C.1
-
22
-
-
0029011224
-
Glycogenosis type II (acid maltase deficiency)
-
Reuser AJ, Kroos MA, Hermans MM, Bijvoet AG, Verbeet MP, Van Diggelen OP, Kleijer WJ, Van der Ploeg AT (1995) Glycogenosis type II (acid maltase deficiency). Muscle Nerve 3:S61-S69
-
(1995)
Muscle Nerve
, vol.3
-
-
Reuser, A.J.1
Kroos, M.A.2
Hermans, M.M.3
Bijvoet, A.G.4
Verbeet, M.P.5
Van Diggelen, O.P.6
Kleijer, W.J.7
Van Der Ploeg, A.T.8
-
23
-
-
33845992187
-
Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy
-
DOI 10.1002/mus.20665
-
Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J, Martiniuk F (2007) Modification of the natural history of adult onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35:70-77 (Pubitemid 46052651)
-
(2007)
Muscle and Nerve
, vol.35
, Issue.1
, pp. 70-77
-
-
Slonim, A.E.1
Bulone, L.2
Goldberg, T.3
Minikes, J.4
Slonim, E.5
Galanko, J.6
Martiniuk, F.7
-
24
-
-
0033837749
-
Identification of two subtypes of infantile acid maltase deficiency
-
DOI 10.1067/mpd.2000.107112
-
Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F (2000) Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 137:283-285 (Pubitemid 30659245)
-
(2000)
Journal of Pediatrics
, vol.137
, Issue.2
, pp. 283-285
-
-
Slonim, A.E.1
Bulone, L.2
Ritz, S.3
Goldberg, T.4
Chen, A.5
Martiniuk, F.6
-
25
-
-
74849085443
-
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
-
Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, Brejova A, Hilz M, Reiners K, Muller-Felber W, Mengel E, Spranger M, Schoser B (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91-97
-
(2010)
J Neurol
, vol.257
, pp. 91-97
-
-
Strothotte, S.1
Strigl-Pill, N.2
Grunert, B.3
Kornblum, C.4
Eger, K.5
Wessig, C.6
Deschauer, M.7
Breunig, F.8
Glocker, F.X.9
Vielhaber, S.10
Brejova, A.11
Hilz, M.12
Reiners, K.13
Muller-Felber, W.14
Mengel, E.15
Spranger, M.16
Schoser, B.17
-
26
-
-
33751211826
-
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease
-
DOI 10.1038/labinvest.3700484, PII 3700484
-
Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC, Bossen E, Kishnani PS, O'Callaghan M (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Investig 86:1208-1220 (Pubitemid 44789911)
-
(2006)
Laboratory Investigation
, vol.86
, Issue.12
, pp. 1208-1220
-
-
Thurberg, B.L.1
Maloney, C.L.2
Vaccaro, C.3
Afonso, K.4
Tsai, A.C.-H.5
Bossen, E.H.6
Kishnani, P.S.7
O'Callaghan, M.8
-
27
-
-
84876476681
-
Enzyme replacement therapy in late-onset Pompe disease: A systematic literature review
-
Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951-959
-
(2013)
J Neurol
, vol.260
, pp. 951-959
-
-
Toscano, A.1
Schoser, B.2
-
28
-
-
78649348369
-
Effect of enzyme therapy in juvenile patients with Pompe disease: A three-year open-label study
-
Van Capelle CI, van der Beek NA, Hagemans ML, Arts WF, Hop WC, Lee P, Jaeken J, Frohn-Mulder IM, Merkus PJ, Corzo D, Puga AC, Reuser AJ, van der Ploeg AT (2010) Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. Neuromuscul Disord 20:775-782
-
(2010)
Neuromuscul Disord
, vol.20
, pp. 775-782
-
-
Van Capelle, C.I.1
Van Der Beek, N.A.2
Hagemans, M.L.3
Arts, W.F.4
Hop, W.C.5
Lee, P.6
Jaeken, J.7
Frohn-Mulder, I.M.8
Merkus, P.J.9
Corzo, D.10
Puga, A.C.11
Reuser, A.J.12
Van Der Ploeg, A.T.13
-
29
-
-
0042131675
-
The natural course of infantile Pompe's disease: 20 Original cases compared with 133 cases from the literature
-
DOI 10.1542/peds.112.2.332
-
Van den Hout HMP, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, De Klerk JB, Reuser AJ, van der Ploeg AT (2003) The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332-340 (Pubitemid 36951395)
-
(2003)
Pediatrics
, vol.112
, Issue.2 I
, pp. 332-340
-
-
Van Den, H.H.M.P.1
Hop, W.2
Van Diggelen, O.P.3
Smeitink, J.A.M.4
Smit, G.P.A.5
Poll-The, B.-T.T.6
Bakker, H.D.7
Loonen, M.C.B.8
De Klerk, J.B.C.9
Reuser, A.J.J.10
Van Der, P.A.T.11
-
30
-
-
2942570942
-
Long-term intravenous treatment of Pompe diseasewith recombinant human alpha-glucosidase from milk
-
Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De KlerK JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, van Hirtum H, van Diggelen OP, Boer M, Kroos MA, van Doorn PA, van der Voort E, Sibbles B, van Corven EJ, Brakenhoff JP, van Hove J, Smeitink JA, de Jong G, Reuser AJ, van der Ploeg AT (2004) Long-term intravenous treatment of Pompe diseasewith recombinant human alpha-glucosidase from milk. Pediatrics 113:e448-e457
-
(2004)
Pediatrics
, vol.113
-
-
Van Den Hout, J.M.1
Kamphoven, J.H.2
Winkel, L.P.3
Arts, W.F.4
De KlerK, J.B.5
Loonen, M.C.6
Vulto, A.G.7
Cromme-Dijkhuis, A.8
Weisglas-Kuperus, N.9
Hop, W.10
Van Hirtum, H.11
Van Diggelen, O.P.12
Boer, M.13
Kroos, M.A.14
Van Doorn, P.A.15
Van Der Voort, E.16
Sibbles, B.17
Van Corven, E.J.18
Brakenhoff, J.P.19
Van Hove, J.20
Smeitink, J.A.21
De Jong, G.22
Reuser, A.J.23
Van Der Ploeg, A.T.24
more..
-
31
-
-
0034729963
-
Recombinant human alpha-glucosidase from rabbit milk in Pompe patients
-
Van den Hout JM, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT (2000) Recombinant human alphaglucosidase from rabbitmilk in Pompe patients. Lancet 356:397-398 (Pubitemid 30487498)
-
(2000)
Lancet
, vol.356
, Issue.9227
, pp. 397-398
-
-
Van Hout, H.D.1
Reuser, A.J.J.2
Vulto, A.G.3
Christa, B.L.M.4
Cromme-Dijkhuis, A.5
Van Der, P.A.T.6
-
32
-
-
59149086832
-
Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease
-
Van der Beek NA, Hagemans ML, Reuser AJ, Hop WC, Van der Ploeg AT, Van Doorn PA, Wokke JH (2009) Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 19:113-117
-
(2009)
Neuromuscul Disord
, vol.19
, pp. 113-117
-
-
Van Der Beek, N.A.1
Hagemans, M.L.2
Reuser, A.J.3
Hop, W.C.4
Van Der Ploeg, A.T.5
Van Doorn, P.A.6
Wokke, J.H.7
-
33
-
-
84867899868
-
Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase alfa
-
Van der Ploeg AT, Barohn R, Carlson L, Charrow J, Clemens PR, Hopkin RJ, Kishnani PS, Laforet P, Morgan C, Nations S, Pestronk A, Plotkin H, Rosenbloom BE, Sims KB, Tsao E (2012) Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase alfa. Mol Genet Metab 107:456-461
-
(2012)
Mol Genet Metab
, vol.107
, pp. 456-461
-
-
Van Der Ploeg, A.T.1
Barohn, R.2
Carlson, L.3
Charrow, J.4
Clemens, P.R.5
Hopkin, R.J.6
Kishnani, P.S.7
Laforet, P.8
Morgan, C.9
Nations, S.10
Pestronk, A.11
Plotkin, H.12
Rosenbloom, B.E.13
Sims, K.B.14
Tsao, E.15
-
34
-
-
77950963839
-
A randomized study of alglucosidase alfa in late-onset Pompe's disease
-
Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA (2010) A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med 362:1396-1406
-
(2010)
N Engl J Med
, vol.362
, pp. 1396-1406
-
-
Van Der Ploeg, A.T.1
Clemens, P.R.2
Corzo, D.3
Escolar, D.M.4
Florence, J.5
Groeneveld, G.J.6
Herson, S.7
Kishnani, P.S.8
Laforet, P.9
Lake, S.L.10
Lange, D.J.11
Leshner, R.T.12
Mayhew, J.E.13
Morgan, C.14
Nozaki, K.15
Park, D.J.16
Pestronk, A.17
Rosenbloom, B.18
Skrinar, A.19
Van Capelle, C.I.20
Van Der Beek, N.A.21
Wasserstein, M.22
Zivkovic, S.A.23
more..
-
35
-
-
0003579225
-
Clinical examination, differential diagnosis and classification
-
Walton J, Karpati G, Hilton-Jones D (eds) Churchill Livingstone, New York
-
Walton J, Rowland L (1994) Clinical examination, differential diagnosis and classification. In: Walton J, Karpati G, Hilton-Jones D (eds) Disorders of voluntary muscle, 6th edn. Churchill Livingstone, New York, p 1771
-
(1994)
Disorders of Voluntary Muscle, 6th Edn.
, pp. 1771
-
-
Walton, J.1
Rowland, L.2
-
36
-
-
23944445667
-
The natural course of non-classic Pompe's disease; a review of 225 published cases
-
DOI 10.1007/s00415-005-0922-9
-
Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, van der Ploeg AT (2005) The natural course of nonclassic Pompe's disease: a review of 225 published cases. J Neurol 252:875-884 (Pubitemid 41186956)
-
(2005)
Journal of Neurology
, vol.252
, Issue.8
, pp. 875-884
-
-
Winkel, L.P.F.1
Hagemans, M.L.C.2
Van Doorn, P.A.3
Loonen, M.C.B.4
Hop, W.J.C.5
Reuser, A.J.J.6
Van Der, P.A.T.7
-
37
-
-
0029084459
-
Genotype-phenotype correlation in adultonset acid maltase deficiency
-
Wokke JH, Ausems MG, van den Boogaard MJ, Ippel EF, van Diggelene O, Kroos MA, Boer M, Jennekens FG, Reuser AJ, Ploos van Amstel HK (1995) Genotype-phenotype correlation in adultonset acid maltase deficiency. Ann Neurol 38:450-454
-
(1995)
Ann Neurol
, vol.38
, pp. 450-454
-
-
Wokke, J.H.1
Ausems, M.G.2
Van Den Boogaard, M.J.3
Ippel, E.F.4
Van Diggelene, O.5
Kroos, M.A.6
Boer, M.7
Jennekens, F.G.8
Reuser, A.J.9
Ploos Van Amstel, H.K.10
-
38
-
-
53549095724
-
Clinical features of late-onset Pompe disease: A prospective cohort study
-
Wokke JH, Escolar DM, Pestronk A, Jaffe KM, Carter GT, van den Berg LH, Florence J, Mayhew J, Skrinar A, Corzo D, Laforet P (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 38:1236-1245
-
(2008)
Muscle Nerve
, vol.38
, pp. 1236-1245
-
-
Wokke, J.H.1
Escolar, D.M.2
Pestronk, A.3
Jaffe, K.M.4
Carter, G.T.5
Van Den Berg, L.H.6
Florence, J.7
Mayhew, J.8
Skrinar, A.9
Corzo, D.10
Laforet, P.11
|